AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34548089 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program for 8 weeks
Number of subjects: 17
Study 34548089 — intervention group
Group type: COMPARATOR
Intervention: No-exercise control period for 8 weeks
Number of subjects: 17
Study 33740127 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentiated education (intervention group)
Number of subjects: 79
Study 33740127 — intervention group
Group type: COMPARATOR
Intervention: Standard education (control group)
Number of subjects: 79
Study 34463434 — intervention group
Group type: EXPERIMENTAL
Intervention: Voclosporin (23.7 mg twice daily)
Number of subjects: 357
Study 34463434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 357
Study 34463434 — intervention group
Group type: EXPERIMENTAL
Intervention: Voclosporin
Number of subjects: 357
Study 35202553 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg STM
Number of subjects: 68
Study 35202553 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg STM
Number of subjects: 68
Study 35202553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 35822278 — intervention group
Group type: EXPERIMENTAL
Intervention: PPM discharge education
Number of subjects: 116
Study 35822278 — intervention group
Group type: COMPARATOR
Intervention: Traditional discharge education
Number of subjects: 116
Study 33736601 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm solution containing 30 ml 5% sodium bicarbonate solution and 15 ml reformulated simethicone emulsion
Number of subjects: 523
Study 33736601 — intervention group
Group type: COMPARATOR
Intervention: 45 ml 40 °C lukewarm water
Number of subjects: 523
Study 32549127 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft tissue mobilization (STM) and static stretching
Number of subjects: 78
Study 32549127 — intervention group
Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 78
Study 33592607 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical glucocorticoids (TGC)
Number of subjects: 25
Study 33176415 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic scaler with ozonated water (left quadrants)
Number of subjects: 10
Study 33176415 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic scaler (right quadrants)
Number of subjects: 10
Study 36075079 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-based enoxaparin dosing (0.5 mg/kg every 12 hours)
Number of subjects: 146
Study 36075079 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose enoxaparin (40 mg daily for BMI < 40; 40 mg every 12 hours for BMI ≥ 40)
Number of subjects: 146
Study 34152270 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Remote Behavioral Intervention for Tics (ORBIT)
Number of subjects: 112
Study 34152270 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 112
Study 32709872 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain
Number of subjects: 1206
Study 32709872 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain PGS
Number of subjects: 1206
Study 32709872 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic correlation
Number of subjects: 1206
Study 32709872 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 1206
Study 32709872 — intervention group
Group type: EXPERIMENTAL
Intervention: Nine shared functional connectivity (FCs)
Number of subjects: 1206
Study 35490599 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg for 2 weeks
Number of subjects: 30
Study 35490599 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 30
Study 33346091 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy to the prostate bed (51 Gy in 15 fractions, 3.4 Gy per fraction)
Number of subjects: 64
Study 35978361 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block (FICB) administered by paramedics
Number of subjects: 1400
Study 35978361 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1400
Study 35978361 — intervention group
Group type: EXPERIMENTAL
Intervention: FICB
Number of subjects: 1400
Study 33455792 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme-treated soybean meal (ESBM)
Number of subjects: 12
Study 33455792 — intervention group
Group type: COMPARATOR
Intervention: Standard soybean meal (SBM)
Number of subjects: 12
Study 33455792 — intervention group
Group type: EXPERIMENTAL
Intervention: Low content of CP (10%) with no soy protein
Number of subjects: 12
Study 32689993 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the Health Belief Model (HBM)
Number of subjects: 160
Study 32689993 — intervention group
Group type: COMPARATOR
Intervention: Usual educational programs of rural health center
Number of subjects: 160
Study 33570699 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 120
Study 33570699 — intervention group
Group type: COMPARATOR
Intervention: Conventional instrumented (CI)
Number of subjects: 120
Study 34250911 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond Universal Agent (Group A)
Number of subjects: 254
Study 34250911 — intervention group
Group type: COMPARATOR
Intervention: Seal & Protect Agent (Group B)
Number of subjects: 254
Study 32393099 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered hypertonic saline nasal irrigation with budesonide respule
Number of subjects: 52
Study 32393099 — intervention group
Group type: COMPARATOR
Intervention: Buffered hypertonic saline nasal irrigation with placebo respule
Number of subjects: 52
Study 34148802 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided long-axis (LAX) femoral artery catheterization
Number of subjects: 90
Study 34148802 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided short-axis (SAX) femoral artery catheterization
Number of subjects: 90
Study 33567127 — intervention group
Group type: EXPERIMENTAL
Intervention: Marfan syndrome (MFS) cohort
Number of subjects: 406
Study 33567127 — intervention group
Group type: COMPARATOR
Intervention: Reference population
Number of subjects: 406
Study 33567127 — intervention group
Group type: EXPERIMENTAL
Intervention: MFS cohort
Number of subjects: 406
Study 34799518 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-facilitated groups without a discussion guide
Number of subjects: 25
Study 34799518 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-facilitated groups with a one-page discussion guide
Number of subjects: 25
Study 34799518 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention (both groups)
Number of subjects: 25
Study 32227625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioversol 320
Number of subjects: 270
Study 32227625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioversol 350
Number of subjects: 270
Study 32227625 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopromide 370
Number of subjects: 270
Study 33772349 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Diagnostic Test (RDT)
Number of subjects: 3322
Study 33772349 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopy
Number of subjects: 3322
Study 33772349 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional diagnostic tools (RDT and microscopy)
Number of subjects: 3322
Study 36377263 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-based guided meditations
Number of subjects: 32
Study 36377263 — intervention group
Group type: COMPARATOR
Intervention: Standalone mobile app guided meditations
Number of subjects: 32
Study 33397540 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary assisted dying
Number of subjects: 164
Study 33397540 — intervention group
Group type: COMPARATOR
Intervention: Long-term illness
Number of subjects: 164
Study 35992128 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian network model for predicting new-onset diabetes
Number of subjects: 15934
Study 35992128 — intervention group
Group type: COMPARATOR
Intervention: Logistic regression model using the same three predictors
Number of subjects: 15934
Study 32146318 — intervention group
Group type: EXPERIMENTAL
Intervention: Practicing discrete key pressing sequences with letter stimuli
Number of subjects: 0
Study 32146318 — intervention group
Group type: EXPERIMENTAL
Intervention: Practicing discrete key pressing sequences with meaningless stimuli
Number of subjects: 0
Study 33815533 — intervention group
Group type: EXPERIMENTAL
Intervention: α-viniferin administered three times a day for ten days using a sterile cotton swab stick.
Number of subjects: 0
Study 33815533 — intervention group
Group type: EXPERIMENTAL
Intervention: α-viniferin
Number of subjects: 0
Study 32150085 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM acupoint application
Number of subjects: 200
Study 32150085 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupoint application
Number of subjects: 200
Study 33622079 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone bleaching with the ozone-releasing machine
Number of subjects: 48
Study 33622079 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical bleaching with 40% hydrogen peroxide (H2O2) gel
Number of subjects: 48
Study 33622079 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% H2O2 gel activated with the diode laser
Number of subjects: 48
Study 35578151 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab plus carfilzomib and dexamethasone (Isa-Kd)
Number of subjects: 46
Study 33446440 — intervention group
Group type: EXPERIMENTAL
Intervention: Pompage therapy (24 sessions over 8 weeks, 40 minutes each, three times a week)
Number of subjects: 56
Study 33446440 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified what intervention was used)
Number of subjects: 56
Study 33734538 — intervention group
Group type: EXPERIMENTAL
Intervention: ENT + GC (Genetic Counseling)
Number of subjects: 49
Study 33510567 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic intra-abdominal ultrasound-guided radiofrequency ablation
Number of subjects: 110
Study 36162790 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking-focused proactive counseling intervention (6 telephone coaching sessions over 8-14 weeks)
Number of subjects: 380
Study 36162790 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking-focused proactive counseling intervention
Number of subjects: 380
Study 36162790 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 380
Study 33514367 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaloba® liquid
Number of subjects: 160
Study 33514367 — intervention group
Group type: COMPARATOR
Intervention: Placebo liquid
Number of subjects: 160
Study 33514367 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaloba® tablet
Number of subjects: 160
Study 33514367 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 160
Study 33514367 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms combined
Number of subjects: 160
Study 33514367 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 160
Study 32720353 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulation therapy (OAT) continued
Number of subjects: 436
Study 32720353 — intervention group
Group type: COMPARATOR
Intervention: OAT discontinued
Number of subjects: 436
Study 36141520 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic pictorial cigarette warning labels
Number of subjects: 661
Study 36141520 — intervention group
Group type: COMPARATOR
Intervention: Text-only labels
Number of subjects: 661
Study 36141520 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical scenarios of manipulated prices
Number of subjects: 661
Study 36141520 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical scenarios of graphic pictorial cigarette warning labels
Number of subjects: 661
Study 35614518 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal weight training (AWT)
Number of subjects: 40
Study 35614518 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal weight training + cough machine (AWT + CM)
Number of subjects: 40
Study 35614518 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 34565357 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving intervention delivered by first-line managers
Number of subjects: 0
Study 34565357 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving a lecture
Number of subjects: 0
Study 34844061 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted manual-assisted problem-solving training (C-MAP) plus treatment as usual (TAU)
Number of subjects: 221
Study 34844061 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 221
Study 34844061 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted manual-assisted problem-solving training (C-MAP)
Number of subjects: 221
Study 33960946 — intervention group
Group type: EXPERIMENTAL
Intervention: Water immersion (WI)
Number of subjects: 526
Study 33960946 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation (AI)
Number of subjects: 526
Study 32401715 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (lopinavir 400 mg and ritonavir 100 mg every 12 h, ribavirin 400 mg every 12 h, and three doses of 8 million international units of interferon beta‐1b on alternate days for 14 days)
Number of subjects: 127
Study 32401715 — intervention group
Group type: COMPARATOR
Intervention: Control group (lopinavir 400 mg and ritonavir 100 mg every 12 h for 14 days)
Number of subjects: 127
Study 34209647 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided forest therapy
Number of subjects: 37
Study 34209647 — intervention group
Group type: COMPARATOR
Intervention: Guided forest therapy program
Number of subjects: 37
Study 35758850 — intervention group
Group type: EXPERIMENTAL
Intervention: SpikoGen® vaccine
Number of subjects: 300
Study 35758850 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 300
Study 34765460 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based Cognitive Bias Modification intervention
Number of subjects: 749
Study 34765460 — intervention group
Group type: COMPARATOR
Intervention: Cluster 2 (41.0%, n = 307)
Number of subjects: 749
Study 34765460 — intervention group
Group type: COMPARATOR
Intervention: Cluster 3 (33.8%, n = 253)
Number of subjects: 749
Study 36253714 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 μg GTN administered in the catheter immediately after recanalization
Number of subjects: 40
Study 36253714 — intervention group
Group type: COMPARATOR
Intervention: Normal saline administered in the catheter immediately after recanalization
Number of subjects: 40
Study 34761854 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention targeting nutrition environment, curricula, and community; duration of six months.
Number of subjects: 862
Study 34761854 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 862
Study 35378542 — intervention group
Group type: EXPERIMENTAL
Intervention: ImmunoCAP® fluorescence enzyme immunoassay (FEIA)
Number of subjects: 19
Study 35378542 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind placebo-controlled food challenge (DBPCFC)
Number of subjects: 19
Study 35378542 — intervention group
Group type: EXPERIMENTAL
Intervention: ImmunoCAP® ISAC
Number of subjects: 19
Study 32247251 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaktor app
Number of subjects: 149
Study 32247251 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 149
Study 35788622 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (20 mg/d on days 1-5, then 10 mg/d on days 6-10)
Number of subjects: 546
Study 35788622 — intervention group
Group type: COMPARATOR
Intervention: Standard dexamethasone (6 mg/d for 10 days)
Number of subjects: 546
Study 35788622 — intervention group
Group type: COMPARATOR
Intervention: Oxygen support standard of care (o2SC)
Number of subjects: 546
Study 35788622 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 546
Study 35788622 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNo2
Number of subjects: 546
Study 33331088 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 30
Study 33331088 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32472620 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol beverage sufficient to produce a breath alcohol concentration of 0.08 g/dl
Number of subjects: 26
Study 32472620 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 26
Study 35085503 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal faricimab 6.0 mg every 8 weeks
Number of subjects: 1891
Study 35085503 — intervention group
Group type: EXPERIMENTAL
Intervention: Faricimab per personalised treatment interval (PTI)
Number of subjects: 1891
Study 35085503 — intervention group
Group type: COMPARATOR
Intervention: Aflibercept 2.0 mg every 8 weeks
Number of subjects: 1891
Study 35085503 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocular adverse events
Number of subjects: 1891
Study 33293225 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mm steeper lens
Number of subjects: 17
Study 33293225 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimally fitted lens
Number of subjects: 17
Study 33293225 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mm flatter lens
Number of subjects: 17
Study 33293225 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal measurement
Number of subjects: 17
Study 33293225 — intervention group
Group type: COMPARATOR
Intervention: Conjunctival staining
Number of subjects: 17
Study 33293225 — intervention group
Group type: COMPARATOR
Intervention: Comfort scoring
Number of subjects: 17
Study 34325186 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 68
Study 34325186 — intervention group
Group type: COMPARATOR
Intervention: Standardized analgesia protocol (Control)
Number of subjects: 68
Study 32830855 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-patient racial/ethnic concordance
Number of subjects: 0
Study 32651769 — intervention group
Group type: EXPERIMENTAL
Intervention: Proctored guidance
Number of subjects: 70
Study 32651769 — intervention group
Group type: COMPARATOR
Intervention: Simulator generated guidance
Number of subjects: 70
Study 32651769 — intervention group
Group type: COMPARATOR
Intervention: No guidance
Number of subjects: 70
Study 33256237 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell-based therapy
Number of subjects: 0
Study 36398328 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Steps Wellbeing intervention
Number of subjects: 496
Study 36398328 — intervention group
Group type: COMPARATOR
Intervention: Baby Care control arm
Number of subjects: 496
Study 34598813 — intervention group
Group type: EXPERIMENTAL
Intervention: Telotristat ethyl (TE)
Number of subjects: 0
Study 32311473 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg intravenous linezolid
Number of subjects: 30
Study 32311473 — intervention group
Group type: EXPERIMENTAL
Intervention: 900- and 1200-mg linezolid doses
Number of subjects: 30
Study 32311473 — intervention group
Group type: EXPERIMENTAL
Intervention: Doubling the standard dose of linezolid
Number of subjects: 30
Study 35802209 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention in conjunction with behavioral treatment (BT)
Number of subjects: 58
Study 35802209 — intervention group
Group type: COMPARATOR
Intervention: Behavioral treatment (BT) active control condition
Number of subjects: 58
Study 33852940 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg/day)
Number of subjects: 76
Study 33852940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 36501158 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g/kg BM of glucose (Glu)
Number of subjects: 16
Study 36501158 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g/kg BM of fructose (Fru)
Number of subjects: 16
Study 36501158 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g/kg BM of glucose/fructose (GluFru)
Number of subjects: 16
Study 36501158 — intervention group
Group type: COMPARATOR
Intervention: 0.2 g sucralose (placebo)
Number of subjects: 16
Study 32594615 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity 4-week anti-idling intervention (onsite signage, newsletters, fact sheets)
Number of subjects: 12
Study 32594615 — intervention group
Group type: COMPARATOR
Intervention: Control group (2 schools)
Number of subjects: 12
Study 32119714 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen time (ST)
Number of subjects: 526
Study 32119714 — intervention group
Group type: COMPARATOR
Intervention: Playing outside (PO)
Number of subjects: 526
Study 35908116 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time fMRI neurofeedback targeting the left medial prefrontal cortex (8 sessions of 30 minutes each)
Number of subjects: 20
Study 35908116 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (16 sessions)
Number of subjects: 20
Study 34859105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultimaster (biodegradable polymer DES)
Number of subjects: 362
Study 34859105 — intervention group
Group type: COMPARATOR
Intervention: Magmaris (magnesium bioresorbable scaffold)
Number of subjects: 362
Study 35347281 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical B‐VEC treatment
Number of subjects: 9
Study 35347281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 32419310 — intervention group
Group type: EXPERIMENTAL
Intervention: High bicarbonate dialysate concentration (36 mmol/L)
Number of subjects: 56
Study 32419310 — intervention group
Group type: COMPARATOR
Intervention: Bicarbonate dialysate concentration of 30 mmol/L (Control)
Number of subjects: 56
Study 36420538 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of Pregnancy Category (PC) letters in drug labeling
Number of subjects: 162
Study 36420538 — intervention group
Group type: COMPARATOR
Intervention: Absence of Pregnancy Category (PC) letters in drug labeling
Number of subjects: 162
Study 33508990 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU every 2 weeks for 12 weeks)
Number of subjects: 60
Study 32469870 — intervention group
Group type: EXPERIMENTAL
Intervention: Food supplement from pre-conception to term (PC-T)
Number of subjects: 460